Pediatric Rheumatology

Pediatric Rheumatology is the official journal of the Pediatric Rheumatology European Society, and it publishes open access work on musculoskeletal and rheumatic disease in children and adolescents.《儿科风湿病学》是欧洲儿科风湿病学会的会刊，以开放获取方式发表儿童与青少年肌骨及风湿疾病的研究。

Springer Nature handles it through BioMed Central, and the online record calls the title Pediatric Rheumatology Online Journal.刊物由施普林格·自然经 BioMed Central 运营，电子记录里的全名写作儿科风湿病学网络杂志。

Its 2025 impact factor is 2.3 with a five-year figure of 2.8, and the publisher reports 1.9 million downloads for that year.2025 年影响因子 2.3，五年影响因子 2.8，出版方报告的当年下载量是 190 万次。

Clarivate places it at 55 of 190 in paediatrics, a Q2 slot, and at 32 of 58 in rheumatology, which is Q3.科睿唯安把它排在儿科 190 种刊里的第 55，属 Q2，风湿病学 58 种里的第 32，属 Q3。

The 2026 volume is the 24th, and articles appear continuously through the year inside a single numbered issue.2026 年是第 24 卷，文章在年内连续上线，都归在一个编号期里。

Scope

• Eligible work covers the evaluation and treatment of non-surgical musculoskeletal syndromes and diseases in children and adolescents, with autoimmune and rheumatic conditions given as the core.受理范围是儿童与青少年非手术类肌骨综合征与疾病的评估和治疗，自身免疫与风湿类疾病被列为核心。

• The condition list opens with musculoskeletal pain syndromes and runs through rheumatic fever and post-streptococcal syndromes to juvenile idiopathic arthritis.病种清单从肌骨疼痛综合征起头，经风湿热与链球菌感染后综合征，一直列到幼年特发性关节炎。

• Systemic lupus erythematosus and juvenile dermatomyositis follow, together with local and systemic scleroderma.系统性红斑狼疮与幼年皮肌炎紧随其后，局限性硬皮病与系统性硬皮病也在其中。

• Kawasaki disease, Henoch-Schonlein purpura and other vasculitides are named, and so are sarcoidosis and inherited musculoskeletal syndromes.川崎病，过敏性紫癜与其他血管炎都点了名，结节病与遗传性肌骨综合征同样在列。

• Autoinflammatory syndromes close the list, and the wording leaves room for conditions not enumerated.自身炎症综合征收尾，措辞上给清单之外的其他病况留了余地。

• Beyond disease reports, the journal asks for educational advances, drug studies, laboratory and radiological evaluations, and outcome measures.除疾病报告之外，刊物还征教学进展，药物研究，实验室与影像学评估以及结局测量方面的稿子。

• Research articles are the main track and carry a structured abstract of no more than 350 words with three to ten keywords.研究论文是主轨，摘要结构化且不超过 350 词，关键词三到十个。

• That abstract runs through background, methods, results and conclusions, and adds a trial registration line when the paper reports an intervention.摘要按背景，方法，结果，结论四段排，报告干预研究的稿子还要加一行试验注册信息。

• A Short Report suits work that extends something already published, including added controls, confirmation in another setting and negative results.短篇报告适合在既有发表之上再推进的工作，包括补对照，换场景复核以及阴性结果。

• Those reports run 1,000 to 1,500 words with no more than 25 references, and the body is headed Findings rather than Results.这类报告篇幅 1000 到 1500 词，参考文献不超过 25 条，正文标题用发现而非结果。

• Short report abstracts stop at 250 words and use three headings, background, findings and conclusions, which trims a section off the research format.短篇报告的摘要限 250 词，只用背景，发现，结论三段，比研究论文的格式少一节。

• Reviews, commentaries and correspondence complete the list of accepted types, and correspondence carries no abstract.综述，评论与通信构成受理类型的其余部分，通信不配摘要。

• Every manuscript needs a Declarations section with all of its subheadings, and a data availability statement is expected as one of them.每篇稿子都要有声明一节并写全其下各小标题，数据可得性声明是其中一项。

• Repository deposit is mandatory wherever the research community expects it, and the journal endorses the Force 11 data citation principles.凡学术界普遍要求存档的数据都必须入库，刊物还认可 Force 11 的数据引用原则。

• Figures are capped at 10 MB each and additional files at 20 MB, and tables may not use colour or shading.单张图不超过 10 MB，补充文件不超过 20 MB，表格里不许用颜色或底纹。

History

• The journal started in 2003 at the University of Chicago, which is the first imprint in its National Library record.刊物 2003 年在芝加哥大学起步，这是国家医学图书馆记录里的第一个出版方。

• BioMed Central took over in 2007 and moved the imprint to London, where it has stayed under Springer Nature since.2007 年 BioMed Central 接手，出版地移到伦敦，此后归入施普林格·自然，地点没有变动。

• Volume numbering has tracked the calendar one for one, so 2026 is volume 24 and the sum is year minus 2002.卷号与年份一一对应，2026 年是第 24 卷，算法为年份减 2002。

• PubMed carried the title from volume 5 in 2007, and MEDLINE followed from volume 12 in 2014.PubMed 从 2007 年第 5 卷起收录，MEDLINE 则从 2014 年第 12 卷才跟上。

• Continuous publication replaced the older issue rhythm, and the National Library still records a bimonthly frequency that the volume listing no longer shows.连续出版取代了早先的分期节奏，国家医学图书馆的记录仍写着双月刊，卷期列表上已经看不出这个节奏。

• Impact factors over five years are 3.054 in 2021, 3.413 in 2022, 2.8 in 2023, 2.3 in 2024 and 2.3 in 2025, a fall of roughly a quarter from the peak.五年影响因子是 2021 年 3.054，2022 年 3.413，2023 年 2.8，2024 年 2.3，2025 年 2.3，从高点落了约四分之一。

• Total citations reach 3,271 with a cited half-life of 5.7 years, and about 108 articles appear each year.总被引 3271 次，引用半衰期 5.7 年，年发文约 108 篇。

• The 2025 JCI is 0.87 at percentile 71.3, and the whole output is open access, recorded as a gold ratio of 100 percent.2025 年 JCI 为 0.87，百分位 71.3，全部文章开放获取，金色开放比例记为 100%。

• Supplements carry the society's congress proceedings, and the 2026 supplement holds the papers of the 33rd European Paediatric Rheumatology Congress.增刊用来登学会大会的大会论文，2026 年的增刊收的是第 33 届欧洲儿科风湿病学大会的内容。

• Earlier supplements gathered abstracts from the German society for paediatric and adolescent rheumatology and from the CARRA annual meeting.更早的增刊收过德国儿科与青少年风湿病学会的摘要，也收过 CARRA 年会的摘要。

• Single-topic collections are still being commissioned, and one titled Perspectives in Pediatric Rheumatology takes submissions until March 2027.单主题专辑仍在征稿，其中一个题为儿科风湿病学视野的专辑开到 2027 年 3 月。

Editors

• Tadej Avčin at the University Children's Hospital in Ljubljana and Angelo Ravelli at the Istituto Giannina Gaslini in Genoa share the chief editorship.主编由卢布尔雅那大学儿童医院的 Tadej Avčin 与热那亚吉安娜·加斯利尼研究所的 Angelo Ravelli 共同担任。

• Ravelli also holds a chair at the University of Genoa, in the department that covers neuroscience, rehabilitation, ophthalmology and maternal and child sciences.Ravelli 同时在热那亚大学任教，所在系覆盖神经科学，康复，眼科与母婴科学。

• Five senior editors sit above the associate group, among them Elizabeth Ang in Singapore and Michael Beresford in Liverpool.五位高级编辑位于副编辑群之上，新加坡的 Elizabeth Ang 与利物浦的 Michael Beresford 都在其中。

• Christoph Kessel at Münster, Raju Khubchandani in Mumbai and Susan Shenoi in Seattle complete that senior tier.明斯特的 Christoph Kessel，孟买的 Raju Khubchandani 与西雅图的 Susan Shenoi 补全这一层。

• Twenty-four associate editors handle the day to day load, and their institutions run from Lucknow and Melbourne to Riyadh, Zagreb and Cape Town.二十四位副编辑承担日常事务，所在机构从勒克瑙与墨尔本一直铺到利雅得，萨格勒布与开普敦。

• Sulaiman Al-Mayouf in Riyadh, Marija Jelusic in Zagreb and Seza Özen in Ankara are among the European and Middle Eastern names on that list.利雅得的 Sulaiman Al-Mayouf，萨格勒布的 Marija Jelusic 与安卡拉的 Seza Özen 是名单里欧亚一带的几位。

• African and Asian representation comes through Angela Migowa in Nairobi, Swee-Ping Tang in Selayang and Caifeng Li in Beijing.非洲与亚洲的席位由内罗毕的 Angela Migowa，士拉央的 Swee-Ping Tang 与北京的 Caifeng Li 承担。

• North American associate editors include Hanna Kim at the National Institute of Environmental Health Sciences and Pui Y. Lee at Boston Children's Hospital.北美一侧的副编辑有在美国国家环境健康科学研究所的 Hanna Kim 与波士顿儿童医院的 Pui Y. Lee。

• Roughly thirty-five board members sit below them, among them Fabrizio de Benedetti in Rome and Hermine Brunner in Cincinnati.其下还有约三十五位编委，罗马的 Fabrizio de Benedetti 与辛辛那提的 Hermine Brunner 都在其中。

• Alberto Martini and Charles Spencer are listed twice, once on the board and once as founding editors, which records where the journal came from.Alberto Martini 与 Charles Spencer 各出现两次，一次在编委里，一次在创刊编辑里，刊物的来路由此可查。

• Median submission to first decision is 11 days, which is the fastest in this batch and reflects the single-blinded BMC workflow.从投稿到首次决定的中间值 11 天，是本批最快的，反映的是 BMC 那套单盲流程。

• The article processing charge is 2,390 pounds, 3,190 dollars or 2,690 euros, and it is fixed by the date of acceptance.文章处理费为 2390 英镑，3190 美元或 2690 欧元，按录用日期的那一刻定价。

• Authors choose between CC BY and CC BY-NC-ND, and requests for a waiver have to be made at submission rather than after review.作者可在 CC BY 与 CC BY-NC-ND 之间选，减免申请必须在投稿时提出，过了评审就不再受理。

• Manuscripts go in through the Springer Nature submission system under journal number 12969, and a third party may not submit on an author's behalf.稿件经施普林格·自然投稿系统按刊号 12969 递交，且不许第三方代作者投递。